Search

Your search keyword '"Murtaugh Michael P"' showing total 112 results

Search Constraints

Start Over You searched for: Author "Murtaugh Michael P" Remove constraint Author: "Murtaugh Michael P" Database MEDLINE Remove constraint Database: MEDLINE
112 results on '"Murtaugh Michael P"'

Search Results

1. Clinically available immunosuppression averts rejection but not systemic inflammation after porcine islet xenotransplant in cynomolgus macaques.

2. Isolation of Porcine Reproductive and Respiratory Syndrome Virus GP5-Specific, Neutralizing Monoclonal Antibodies From Hyperimmune Sows.

3. Serum cytokine profiles in healthy nonhuman primates are blunted by sedation and demonstrate sexual dimorphism as detected by a validated multiplex immunoassay.

4. Characterization of Emerging Swine Viral Diseases through Oxford Nanopore Sequencing Using Senecavirus A as a Model.

5. Leveraging a Validated in silico Approach to Elucidate Genotype-Specific VP7 Epitopes and Antigenic Relationships of Porcine Rotavirus A.

6. Establishment and characterization of a porcine B cell lymphoma cell line.

7. The PRRSV-Specific Memory B Cell Response Is Long-Lived in Blood and Is Boosted During Live Virus Re-exposure.

8. MinION sequencing of Streptococcus suis allows for functional characterization of bacteria by multilocus sequence typing and antimicrobial resistance profiling.

9. Rapid, Unbiased PRRSV Strain Detection Using MinION Direct RNA Sequencing and Bioinformatics Tools.

10. Temporal Dynamics of Co-circulating Lineages of Porcine Reproductive and Respiratory Syndrome Virus.

11. Characterization of age-related susceptibility of macrophages to porcine reproductive and respiratory syndrome virus.

12. Establishment of Systems to Enable Isolation of Porcine Monoclonal Antibodies Broadly Neutralizing the Porcine Reproductive and Respiratory Syndrome Virus.

13. Associations Between Nutrition, Gut Microbiome, and Health in A Novel Nonhuman Primate Model.

14. Porcine circovirus 2 infection induces IFNβ expression through increased expression of genes involved in RIG-I and IRF7 signaling pathways.

15. Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge.

16. B Cell Tetramer Development for Veterinary Vaccinology.

17. Effect of Booster Vaccination with Inactivated Porcine Epidemic Diarrhea Virus on Neutralizing Antibody Response in Mammary Secretions.

18. Effect of Maternal Antibody Transfer on Antibody Dynamics and Control of Porcine Circovirus Type 2 Infection in Offspring.

19. Longitudinal Surveillance of Porcine Rotavirus B Strains from the United States and Canada and In Silico Identification of Antigenically Important Sites.

20. Team science and the physician-scientist in the age of grand health challenges.

21. Mechanisms of Adaptive Immunity to Porcine Reproductive and Respiratory Syndrome Virus.

22. The science behind One Health: at the interface of humans, animals, and the environment.

23. Effector mechanisms of humoral immunity to porcine reproductive and respiratory syndrome virus.

24. An indirect enzyme-linked immunosorbent assay for the identification of antibodies to Senecavirus A in swine.

25. Interleukin-21 Drives Proliferation and Differentiation of Porcine Memory B Cells into Antibody Secreting Cells.

26. Characterization of anti-porcine epidemic diarrhea virus neutralizing activity in mammary secretions.

27. National reduction in porcine circovirus type 2 prevalence following introduction of vaccination.

28. Diagnostic phylogenetics reveals a new Porcine circovirus 2 cluster.

29. Genomic variation in the porcine immunoglobulin lambda variable region.

30. Applications of Bayesian Phylodynamic Methods in a Recent U.S. Porcine Reproductive and Respiratory Syndrome Virus Outbreak.

31. Genomic and evolutionary inferences between American and global strains of porcine epidemic diarrhea virus.

32. Emergence of a virulent porcine reproductive and respiratory syndrome virus in vaccinated herds in the United States.

33. Innate and adaptive immunity against Porcine Reproductive and Respiratory Syndrome Virus.

34. Advancing One Health Policy and Implementation Through the Concept of One Medicine One Science.

35. Evolutionary diversification of type 2 porcine reproductive and respiratory syndrome virus.

36. Broadly neutralizing antibodies against the rapidly evolving porcine reproductive and respiratory syndrome virus.

37. N-glycosylation profiling of porcine reproductive and respiratory syndrome virus envelope glycoprotein 5.

38. Previous infection of sows with a "mild" strain of porcine epidemic diarrhea virus confers protection against infection with a "severe" strain.

39. Full genome sequence analysis of a wild, non-MLV-related type 2 Hungarian PRRSV variant isolated in Europe.

40. Functional analysis of porcine reproductive and respiratory syndrome virus N-glycans in infection of permissive cells.

41. One Medicine One Science and policy.

42. One Medicine One Science: a framework for exploring challenges at the intersection of animals, humans, and the environment.

43. Characterization of a polymorphic IGLV gene in pigs (Sus scrofa).

44. Advances in swine immunology help move vaccine technology forward.

45. Purifying selection in porcine reproductive and respiratory syndrome virus ORF5a protein influences variation in envelope glycoprotein 5 glycosylation.

46. The spread of type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in North America: a phylogeographic approach.

47. Manufacturing porcine islets: culture at 22 °C has no advantage above culture at 37 °C: a gene expression evaluation.

48. Multiple routes of porcine circovirus type 2 transmission to piglets in the presence of maternal immunity.

49. Epidemiological study of air filtration systems for preventing PRRSV infection in large sow herds.

50. Molecular evolution of PRRSV in Europe: current state of play.

Catalog

Books, media, physical & digital resources